Cytokinetics Inc SEC filings CYTK
Cytokinetics Inc has 1,001 filings in SEC EDGAR's recent list, going back to Mar 9, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 27, 2026 | — |
| 424B5 | Prospectus supplement | May 7, 2026 | — |
| 424B5 | Prospectus supplement | May 5, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 27, 2025 | — |
| S-8 | Employee stock plan registration | Jun 3, 2024 | — |
| 424B5 | Prospectus supplement | May 24, 2024 | — |
| 424B5 | Prospectus supplement | May 22, 2024 | — |
| 424B5 | Prospectus supplement | Mar 1, 2023 | — |
| S-8 | Employee stock plan registration | Mar 1, 2023 | — |
| S-3ASR | Automatic shelf registration | Nov 18, 2022 | — |
| S-8 | Employee stock plan registration | May 31, 2022 | — |
| S-8 | Employee stock plan registration | Nov 5, 2021 | — |
| 424B5 | Prospectus supplement | Jul 21, 2021 | — |
| 424B5 | Prospectus supplement | Jul 19, 2021 | — |
| S-8 | Employee stock plan registration | May 13, 2021 | — |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CYTK (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- South San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1061983
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.